In 1981, the laboratories of Martin Evans and Gail Martin reported the first successful derivation of pluripotent embryonic stem cells from pre-implantation blastocyst-stage mouse embryos 1, 2 . When maintained under defined culture conditions, ESCs possess the unique ability to self-renew indefinitely, as well as a propensity for generating germline chimaeras when introduced into host pre-implantationstage embryos. These features established ESCs as the de facto tool for engineering changes in the mouse genome. Germline transmission of genetically modified ESCs produces animals that can be used in the investigation of gene function and disease modelling. Harnessing their developmental potential, protocols have been developed for the directed differentiation of ESCs to generate therapeutically relevant cell types for potential future use in tissue replacement therapies in regenerative medicine. Recently, ESCs have also been adopted as an in vitro model for early mammalian development, but precisely how well they mimic in vivo lineage progression remains an open question.
Following on from the pioneering work in the mouse, ESC-like lines were derived from several mammalian species, including human 3 . However, it soon became apparent that the developmental potential of mouse ESCs was more robust than that of ESC-like lines from other mammals. Indeed, only mouse and rat ESCs possess the ability to generate germlinetransmitting chimaeras when introduced into embryonic day 2.5 (E2.5) morulae or E3.5 blastocysts. The recent derivation of pluripotent cell lines from isolated epiblast tissue of post-implantation mouse embryos (referred to as epiblast stem cells, EpiSCs) using human ESC derivation and culture conditions 4, 5 has led to the concept of two distinct pluripotent states: naive and primed 6 . Mouse ESCs represent the naive state, which is associated with the preimplantation epiblast and is characterized by the ability to give rise to all somatic cell types and germline competency. In contrast, mouse EpiSCs (and human ESCs) represent a primed state, which in mice resembles the early postimplantation (E5.5) epiblast, and are unable to contribute to chimaeras when introduced into pre-implantation host embryos. Thus mouse EpiSCs and human ESCs are functionally distinct from naive-state ESCs, and represent a different embryonic stage. However, this distinction does not clarify why mouse ESCs differ in their developmental potential and culture requirements from ESCs of other mammalian species, as all are, in principle, derived from the blastocyst stage. Nor does it provide evidence to support the notion that mouse ESCs (or EpiSCs) are the in vitro counterpart of a cell type resident in vivo.
The true identity of ESCs has long been debated. On the one hand, it has been suggested that ESCs might represent an artefactual state: an in vitro culture adaptation with no true in vivo counterpart. A counterpoint argument draws comparison between ESCs and the cells of the inner cell mass (ICM) in the pre-implantation blastocyst-stage embryo. In this issue, Nichols and colleagues 7 address this question and demonstrate that self-renewing embryonic stem cell potential arises following epiblast specification.
They begin by determining the gene expression profiles of cells present across a range of pre-implantation and early post-implantation stages of mouse embryo development (Fig. 1) , and compared these to the expression profiles of mouse ESCs. As baseline conditions for ESC culture, the authors used two culture conditions that promote naive-state pluripotency within ESC populations and facilitate the derivation of ESCs from permissive and non-permissive strains of mice 8 . These culture conditions are based on the dual inhibition of the extracellular signal related kinase (ERK) and glycogen synthase kinase-3 (GSK3) so as to suppress cellular differentiation while maintaining self-renewal -termed the 2i condition. The authors also used 2i medium supplemented with the cytokine LIF (2i-LIF). Marker profiling revealed that ESCs most closely resembled pre-implantation E4.5 epiblast cells.
The expression data presented by Nichols and colleagues 7 supports previous studies that demonstrated that the blastocyst is not a singular stage, but instead comprises a dynamic heterogeneous population of cells encompassing several sequential steps of embryonic development 9, 10 . In the late blastocyst (E4.0-E4.5), the ICM contains two distinct cell types: the pluripotent epiblast, which includes the precursors of almost all somatic and germ cells, and the primitive endoderm (PrE), a predominantly extra-embryonic lineage (Fig. 1) 
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. The epiblast exclusively expresses pluripotency-associated transcription factors such as Nanog, Sox2 and Klf2, whereas PrE precursors are characterized by their expression of Gata6, Gata4, Sox17 and Sox7 (ref. 11).
It has long been known that it is ICM cells of the blastocyst that give rise to ESCs, but, surprisingly, the precise cellular origin of ESCs . The capacity for clonal propagation in 2i-LIF conditions is a distinct feature of naive ESCs, and Nichols and colleagues 7 hypothesized that if cells resident in the late blastocyst are functionally equivalent to naive ESCs, it would be possible to derive ESC lines from single cells isolated from E4.5 embryos. Lineage-specific green fluorescent protein (GFP) reporter mouse lines facilitated the identification and isolation of individual epiblast and PrE cells from E4.5 embryos. These single cells were subjected to an ESC derivation protocol, with ESC colonies emerging from epiblast, but not PrE, precursors. Surprisingly, the number of clonal ESC lines obtained per embryo approximated to the number of epiblast cells within the ICM at E4.5. Thus, every epiblast cell present within an E4.5 blastocyst has the potential to produce naive, germline, competent ESCs. By contrast, ICM cells isolated from embryos staged earlier than E3.75, and older (E5.5) post-implantation epiblast, lacked the capacity to generate ESCs. Indeed, based on marker expression, ICM cells from early blastocyst stages (~E3.5) cannot be categorized as epiblast or PrE because of their co-expression of markers for both of these two ICM lineages 9, 12 . Presumably, early ICM cells represent an immature state of multi-lineage potential. Conversely, early post-implantation epiblast cells have developed beyond the stage of naive pluripotency. Interestingly, 2i-LIF could not revert the post-implantation epiblast cells from a primed to a naive state of pluripotency.
These data suggest that a naive pluripotent state gradually develops within the ICM between E3.75 and E4.0. However, it is unlikely that all ICM cells develop at the same rate. Some epiblast cells are likely to acquire the naive state and the ability to self-renew as ESCs ahead of others. This asynchronous progression of the ICM population to a naive state could account for the reduced efficiency of ESC derivation from E3.75 embryos compared with E4.5 embryos. By E4.5, virtually all epiblast cells had acquired a naive pluripotent state making them 'ESC competent' , and, accordingly, ESC derivation efficiencies were maximal. Collectively, these data suggest that the window of opportunity for when naive mouse ESCs can be captured in vitro from blastocyst-stage embryos is narrow. This may also hold true for other mammalian species.
The detailed transcriptional and functional characterization of the naive state in the mouse should assist in the identification of an equivalent stage in other species, and facilitate the derivation of naive ESCs from non-rodent mammals. Recently, the generation of naive human ESC lines independent of transgenes for stable culture was reported 13, 14 . However, the conditions of stem cell derivation and the culture requirements differed between studies. Moreover, the requirement for fibroblast growth factor (FGF) supplementation in one of the reports begs the question of whether a bona fide naive human ESC state was captured in vitro, as FGF is not required for the culture of naive mouse ESCs (Fig. 1) .
Interestingly, early (E3.5) ICM cells failed to progress to a naive state of pluripotency when cultured under 2i conditions. Hypothesizing that interactions between cells and the extracellular matrix (ECM) within the embryo might facilitate progression of ICM cells (which are initially responsive to FGF and ERK (ref. 11)) to a state of ERK independence, Nichols and colleagues demonstrated that culture of early ICM cells in the presence of ECM components did indeed promote their acquisition of naive pluripotency. These data highlight the critical role played by the ECM in the maturation of ICM cells, and support the beneficial influence of ECM components for ESC propagation. If early ICM cells have multi-lineage potential, these observations also raise the question of whether they can all be equally programmed to a naive pluripotent state when exposed to ECM.
Mounting evidence suggests that FGFproducing epiblast precursors are necessary for the correct specification and maturation of extra-embryonic lineages 10, 15 . The data presented in the current study reveal that the proper maturation of the epiblast may depend on the adjacent extra-embryonic lineages. Extra-embryonic PrE cells express genes encoding ECM components. They are therefore responsible for the deposition of ECM proteins within the ICM, and the assembly of a basement membrane at the PrE-epiblast tissue interface by E4.5. Thus, although the pre-implantation period of embryonic development is characterized by a high degree of cell fate plasticity, A centrosomal route for cancer genome instability
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Despite the widespread occurrence of aneuploidy in cancer cells, the molecular causes for chromosomal instability are not well established. Cyclin B2 is now shown to control a pathway -involving the centrosomal kinases aurora A and Plk1 and the tumour suppressor p53 -the alteration of which causes defective centrosome separation, aneuploidy and tumour development.
A frequent question in cancer biology is whether tumour-associated overexpression of proteins is just a consequence of cell transformation or whether it indicates a causal role for the protein. This question is especially difficult to address in the case of cell cycle regulators, given the general increase in cell proliferation rates observed in tumour cells. Genomic studies have suggested the presence of an expression signature in which the overexpression of about 70 genes is associated with chromosomal instability (CIN) in cancer 1 . This signature is enriched in regulators of the cellular machineries that control centrosome maturation and spindle dynamics, as well as the orderly segregation of chromosomes in every cell cycle (Fig. 1 ). Yet the mechanistic basis for the role of these regulators in tumour development is largely unknown. In this issue, Nam and van Deursen 2 find that two members of the CIN signature, cyclin B1 and cyclin B2, are important for the fidelity of chromosome segregation and centrosome separation, and demonstrate the consequences of their overexpression for tumour development.
Division of cells requires an accurate duplication of the genome during the DNA synthesis phase and proper segregation of the two sets of chromosomes to each of the daughter cells during mitosis. Defects in the cell cycle machinery are commonly linked to cancer, either by promoting unscheduled proliferation, or by allowing the introduction of genomic abnormalities in the daughter cells 3 . The widespread presence of abnormal chromosome number in tumours 4 (a state known as aneuploidy) has inspired the hunt for new molecules that cause this defect in cancer cells when altered. Initial efforts discarded a general role for somatic mutations in mitotic genes, perhaps because of the essential role of many of these proteins in vivo 5 . However, multiple mitotic regulators display aberrant levels of mRNA or protein, and it is now well accepted that both increases and decreases in the expression of mitotic genes can induce CIN by altering the normal mechanisms that protect cells from aberrant chromosome segregation 4, 6 . In the past few years, this has been elegantly demonstrated using loss-and gain-of-function mouse models of mitotic regulators (Fig. 1) . The pioneering work on Mad2, a component of the spindle assembly checkpoint (SAC) that monitors proper microtubule-chromosome attachments, is Figure 1 A general view of centrosomal and mitotic regulators involved in chromosomal instability. Overexpression of some of these molecules induces tumour development in mouse models. Reduced levels of the corresponding proteins (in most cases using heterozygous mutant mice) also results in increased tumour development in mice. Blue molecules are kinases and orange are kinase activators. Other regulators are shown in purple. AurkA and AurkB: aurora A and B.
